Unapproved Drugs (FDA enforcement page) (2024)

Government Record · U.S. Food and Drug Administration · May 9, 2024

U.S. Food, 2024-05-09: FDA page describing its risk-based approach to unapproved prescription drugs: it may permit marketing where there is no approved alternative or insufficient supply, and has worked to remove unapproved drugs since 2006.

The agency permits some unapproved drugs to be marketed if they are relied on by health care professionals to treat serious medical conditions when there is no FDA-approved drug to treat the condition or there is insufficient supply of FDA-approved drugs.

U.S. Food, 2024-05-09: FDA page describing its risk-based approach to unapproved prescription drugs: it may permit marketing where there is no approved alternative or insufficient supply, and has worked to remove unapproved drugs since 2006. C2 FDA policy page. document_date is the page's own "Content current as of: 05/09/2024" value, printed in the page sidebar. (Accessed 2026-11-21.) Page also lists DESI coverage and GRASE/grandfathering criteria. text_file=A_14.txt Study type: regulatory record.